Ȩ > Publication > ±¹ Á¦

ÀÛ¼ºÀÚ :      ÀÛ¼ºÀÏ :     2009-02-25 (15:00:12)
À̸ÞÀÏ :      Á¶È¸¼ö :     14846
ȨÆäÀÌÁö :      ¾ÆÀÌÇÇ :     ***.***.***.***
±ÛÁ¦¸ñ :     Anti-obesity effects of alpha-lipoic acid mediated by suppression of hypothalamic AMP-activated prot
 
Nat Med. 2004 Jul;10(7):727-33. Epub 2004 Jun 13.

Anti-obesity effects of alpha-lipoic acid mediated by suppression of hypothalamic AMP-activated protein kinase.

Kim MS, Park JY, Namkoong C, Jang PG, Ryu JW, Song HS, Yun JY, Namgoong IS, Ha J, Park IS, Lee IK, Viollet B, Youn JH, Lee HK, Lee KU.

Department of Internal Medicine, University of Ulsan College of Medicine, 138-736 Poongnap-dong, Songpa-ku, Seoul 138-736, Korea.

AMP-activated protein kinase (AMPK) functions as a fuel sensor in the cell and is activated when cellular energy is depleted. Here we report that alpha-lipoic acid (alpha-LA), a cofactor of mitochondrial enzymes, decreases hypothalamic AMPK activity and causes profound weight loss in rodents by reducing food intake and enhancing energy expenditure. Activation of hypothalamic AMPK reverses the effects of alpha-LA on food intake and energy expenditure. Intracerebroventricular (i.c.v.) administration of glucose decreases hypothalamic AMPK activity, whereas inhibition of intracellular glucose utilization through the administration of 2-deoxyglucose increases hypothalamic AMPK activity and food intake. The 2-deoxyglucose-induced hyperphagia is reversed by inhibiting hypothalamic AMPK. Our findings indicate that hypothalamic AMPK is important in the central regulation of food intake and energy expenditure and that alpha-LA exerts anti-obesity effects by suppressing hypothalamic AMPK activity.

PMID: 15195087 [PubMed - indexed for MEDLINE]

 
 
 
name :
password :
  comment :
 
 
ÀÌÀü±Û ¸ñ·Ï »õ±Û¾²±â ÀÀ´ä±Û¾²±â ±Û¼öÁ¤Çϱ⠱ÛÁö¿ì±â ´ÙÀ½±Û



76 A transcriptional factor decoy against AP-1 suppresses TGF-beta1-induced type I collagen gene expres  2009.02.2617652
75 Circular dumbbell AP-1 and E2F decoy oligodeoxynucleotide based antiproliferative gene therapy  2009.02.2611889
74 E2F decoy oligodeoxynucleotides on neointimal hyperplasia in canine vein graft.  2009.02.2517741
73 Inhibitory effects of novel E2F decoy oligodeoxynucleotides on mesangial cell proliferation by coexp  2009.02.2522452
72 E2F decoy oligodeoxynucleotides effectively inhibit growth of human tumor cells.  2009.02.2518238
71 Advantages of the circular dumbbell decoy in gene therapy and studies of gene regulation.  2009.02.2512566
70 Dexamethasone regulates AP-1 to repress TNF-alpha induced MCP-1 production in human glomerular endot  2009.02.2524713
69 Relationship between serum adiponectin and leptin concentrations and body fat distribution.  2009.02.2515763
68 Ramipril treatment suppresses islet fibrosis in Otsuka Long-Evans Tokushima fatty rats.  2009.02.2537568
67 Inhibition of ATP-sensitive K+ channels by taurine through a benzamido-binding site on sulfonylurea  2009.02.2520593
66 Tumor necrosis factor-alpha induces fractalkine expression preferentially in arterial endothelial ce  2009.02.2517298
65 Sp1-decoy oligodeoxynucleotide inhibits high glucose-induced mesangial cell proliferation.  2009.02.2515712
64 Transcription factor decoy for AP-1 reduces mesangial cell proliferation and extracellular matrix pr  2009.02.2517078
63 SREBP-1c mediates the insulin-dependent hepatic glucokinase expression.  2009.02.2517715
62 Differential regulation of human and mouse orphan nuclear receptor small heterodimer partner promote  2009.02.2518787
Anti-obesity effects of alpha-lipoic acid mediated by suppression of hypothalamic AMP-activated prot  2009.02.2514846
60 Effect of antisense TGF-beta1 oligodeoxynucleotides in streptozotocin- induced diabetic rat kidney.  2009.02.2514937
59 Taurine increases glucose sensitivity of UCP2-overexpressing {beta}-cells by ameliorating mitochondr  2009.02.2514905
58 Analysis of proteome and transcriptome of tumor necrosis factor alpha stimulated vascular smooth mus  2009.02.2517501
57 Prevention and treatment of macroangiopathy: focusing on oxidative stress.  2009.02.2517721
[1] 2 [3][4][5]
¸ñ·Ï »õ±Û¾²±â